Could COVID-19 studies already be providing clues about what went wrong with the long haulers and people with post-infectious chronic fatigue syndrome (ME/CFS), fibromyalgia and other diseases? Two articles in the New York Times – a feature length one,...
An old drug called spironolactone opens the door to a new generation of more effective Epstein-Barr virus drugs that could help with chronic fatigue syndrome, long COVID and other diseases.
A couple of weeks ago Health Rising posted a kind of wakeup call for the COVID-19 long haulers. Borne out of decades of experience with ME/CFS, it was admittedly a pretty harsh piece – not easy to take in. An Open Letter to the COVID-19 Long Hauler Community...
“If you look anecdotally, there is no question that there are a considerable number of individuals who have a post-viral syndrome that in many respects incapacitates them for weeks and weeks following so-called recovery. They report symptoms such as brain fog,...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.